Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2008 1
2009 1
2010 2
2012 2
2013 1
2014 1
2015 2
2016 2
2017 2
2018 2
2019 3
2021 2
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.
Kholodenko IV, Kalinovsky DV, Doronin II, Deyev SM, Kholodenko RV. Kholodenko IV, et al. J Immunol Res. 2018 Jul 11;2018:7394268. doi: 10.1155/2018/7394268. eCollection 2018. J Immunol Res. 2018. PMID: 30116755 Free PMC article. Review.
Cell-based therapies of liver diseases: age-related challenges.
Yarygin KN, Lupatov AY, Kholodenko IV. Yarygin KN, et al. Among authors: kholodenko iv. Clin Interv Aging. 2015 Dec 1;10:1909-24. doi: 10.2147/CIA.S97926. eCollection 2015. Clin Interv Aging. 2015. PMID: 26664104 Free PMC article. Review.
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.
Kalinovsky DV, Kibardin AV, Kholodenko IV, Svirshchevskaya EV, Doronin II, Konovalova MV, Grechikhina MV, Rozov FN, Larin SS, Deyev SM, Kholodenko RV. Kalinovsky DV, et al. Among authors: kholodenko iv. J Immunother Cancer. 2022 Jun;10(6):e004646. doi: 10.1136/jitc-2022-004646. J Immunother Cancer. 2022. PMID: 35764367 Free PMC article.
32 results